|
Szilard Voros is a Hungarian-born American cardiologist and globally renowned leading research scientist in advanced cardiovascular imaging, biomarkers, lipoprotein metabolism and genomics. He currently serves as an Associate Professor of Medicine/Cardiology and Radiology, and Director of Advanced Cardiovascular MR and CT Research at the Department of Radiology and Cardiology at Stony Brook University Medical Center, State University of New York. He previously served as the Chief Scientific Officer, Chief of Cardiovascular Prevention, and Medical Director of Cardiac MR and CT at Piedmont Hospital in Atlanta, Georgia, and as a Clinical Associate Professor of Medicine at the Medical College of Georgia. He is a founding member and Fellow of the Society of Cardiovascular Computed Tomography (FSCCT), Fellow of the American College of Cardiology (FACC) and Fellow of the American Heart Association (FAHA). ==Biography== In 1996, as a Summa Cum Laude graduate of the University Medical School of Pécs in Hungary, Dr. Voros moved to the United States to pursue his Internship and Residency in Internal Medicine at the University of Alabama at Birmingham from 1997 to 2000. In 2000,he was invited to serve as Clinical Instructor in Medicine and Chief Medical Resident at the University of Alabama at Birmingham. While at UAB, Dr. Voros was inspired to pursue cardiology and non-invasive cardiovascular imaging.Under the mentorship of Dr. Navin Nanda and Dr. Gerald Pohost, both globally renowned expert cardiologists and scientists in their respective specialties, Dr. Voros furthered his interest in cardiovascular imaging. As he would later discover, this interest would become his passion. Dr. Voros was one of the first handful of physicians globally, who were Level III trained in Cardiovascular Magnetic Resonance Imaging and Computed Tomography. In 2008, Fox 7 News aired a Health Edge special on The Family Heart Disease Program, a Voros led initiative that identified family members at high risk of developing coronary artery disease and educated them on how to reduce the risks for themselves and their families.〔()〕 Most recently, Voros was interviewed on Fox 5 News for a Health Watch special on the Corus CAD test,a blood-based test that measures the expression levels of 23 genes that have demonstrated to indicate obstructive coronary artery disease (CAD). Dr. Voros has published extensively in the field of advanced cardiovascular imaging. He regularly lectures at national and international meetings, including many prestigious conferences sponsored by the American College of Cardiology. Working with CardioDx, Inc (Palo Alto, CA), he recently published a paper in the Annals of Internal Medicine describing the first genomic blood-based diagnostic test for the detection of significant blockages in the heart. Dr. Voros is independently funded to do important clinical research on advanced cardiovascular imaging, atherosclerosis and lipoprotein abnormalities. Dr. Voros and his team recently completed the ATLANTA I and ATLANTA II studies, which focused on assessing the morphology and other characteristics of blockages in the heart using heart catheterization, cardiac CT, intravascular ultrasound, and near infrared spectroscopy. In 2010, Voros and his team published an article on their advanced method of coronary artery calcium quantification, the Lesion Specific Calcium Score. This method has been shown, through research, to be superior to the Agatston Score. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Szilard Voros」の詳細全文を読む スポンサード リンク
|